Clinical Trial: Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073534) titled 'Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors' on July 09.

Brief Summary: This study is an open, multicenter phase I/II clinical study. The entire study is divided into three stages: dose escalation, dose expansion, and efficacy expansion. Objective: To evaluate the objective response rate (ORR), safety and tolerability of the combination of SHR-1501 and adibelizumab in the treatment of advanced malignant tumors, and to provide the recommended dose (RP2D) for subsequent clinical studies.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Patients With Advanced o...